Approval · Notice of Compliance 23482 · 2020
PROPOFOL INJECTION: Notice of Compliance 23482
Issued April 20, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 23482
- Date
- April 20, 2020
- Company
- Baxter CorporationMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Labelling Only
- Reason
- Transfer od din ownership, product name change, updatedd labes, package insert and product monograph
- Canadian reference product
- DIPRIVAN (Aspen Pharmacare Canada Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PROPOFOL INJECTION | 02244379 | Marketed |
Medicinal ingredients
- PROPOFOL 10 MG per ML